Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsORALGeneric

CLOXACILLIN SODIUM

CLOXACILLIN SODIUM

Standard Dose
EQ 125MG BASE/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued

Key Takeaways

  • Primary indication: Marketing status: Discontinued
  • Approval overview CLOXACILLIN SODIUM is listed in Drugs@FDA under application 062978 (ANDA).
  • Marketing status: Discontinued Active ingredient CLOXACILLIN SODIUM Form and strength FOR SOLUTION;ORAL - EQ 125MG BASE/5ML Sponsor TEVA Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview CLOXACILLIN SODIUM is listed in Drugs@FDA under application 062978 (ANDA). Marketing status: Discontinued Active ingredient CLOXACILLIN SODIUM Form and strength FOR SOLUTION;ORAL - EQ 125MG BASE/5ML Sponsor TEVA Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.